emerging treatment options for lower- and higher-risk mds and ongoing trials
Published 9 months ago • 78 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
4:28
current and emerging treatment options for mds
-
1:02
update on treatments for high- and low-risk mds
-
3:38
a new set of treatment options for low-risk mds
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:08
approved and emerging treatment options for transplant-ineligible patients with high-risk mds
-
2:55
current and emerging treatments for mf: an update from ash 2023
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
1:20
the current standard of care for patients with lower-risk mds
-
11:53
the optimal treatment of lower risk mds
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:45
a phase ii study of elritercept for lower-risk mds
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:25
prognosis and treatment in high-risk mds
-
2:16
current and future treatment approaches for hr-mds